Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Announces Strategic Collaboration with IQT

Published: Tuesday, May 01, 2012
Last Updated: Tuesday, May 01, 2012
Bookmark and Share
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.

The technology is being developed for the Department of Homeland Security Science and Technology Directorate (DHS S&T), an IQT customer agency, and the National Bioforensic Analysis Center, a DHS S&T laboratory.

"OpGen is the leader in developing Whole Genome Mapping technologies for use with next generation sequencing (NGS) analysis pipelines," said Simon Davidson, partner on IQT's Investments team. "The company is the ideal partner to develop new software for high performance microbial data analysis to increase the speed and accuracy of analyzing samples from different sources to detect potential bio-threat organisms that may pose a danger to public health."

The enhanced application will automate the generation of OpGen's Whole Genome Maps for use in high-throughput genomic assembly and analysis pipelines. The suite of applications in the pipeline will automatically align DNA sequence data to a map of the entire genome and recommend the most accurate finished sequences derived from the highest confidence alignments. The software system is being developed for use with computer clusters and cloud computing to provide rapid, accurate, reproducible and standardized assembly of microbial genome sequences.

"Combining OpGen's Whole Genome Maps with next-generation sequencing saves finishing cost and time while significantly increasing accuracy," said Richard Moore, M.D., Ph.D., chief scientific officer of OpGen. "The additional automation to be provided by this collaboration will make the finishing process much more efficient. In addition, this project will enable more flexible configuration of the Argus(R) system allowing us to better meet the analysis needs of our customers."

"We are pleased to partner with IQT to develop innovative tools for high-throughput, whole genome, sequence analysis," said Douglas White, chief executive officer of OpGen. "Our ultimate goal is to develop systems, databases and services that simplify and standardize processes and information to enable the broader adoption of next-generation sequencing and Whole Genome Mapping for practical application in the biodefense, public health and clinical markets."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen and Hitachi Enter into an Agreement
The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.
Thursday, October 17, 2013
OpGen Assists 100K Genome Project
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.
Thursday, December 20, 2012
OpGen Announces Formation of Public Health Consortium
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.
Friday, May 18, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
OpGen Receives Frost & Sullivan New Product Innovation Award
OpGen, Inc. announces the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation for their Whole Genome Mapping System.
Wednesday, August 24, 2011
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
The Epigenetic Influences of Chronic Pain
Researchers at Drexel University College of Medicine are aiming to identify new molecular mechanisms involved in pain.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!